Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

195 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical performance of 68Ga-PSMA-11 PET/MRI for the detection of recurrent prostate cancer following radical prostatectomy.
Kranzbühler B, Nagel H, Becker AS, Müller J, Huellner M, Stolzmann P, Muehlematter U, Guckenberger M, Kaufmann PA, Eberli D, Burger IA. Kranzbühler B, et al. Among authors: burger ia. Eur J Nucl Med Mol Imaging. 2018 Jan;45(1):20-30. doi: 10.1007/s00259-017-3850-x. Epub 2017 Oct 14. Eur J Nucl Med Mol Imaging. 2018. PMID: 29032394
Clinical impact of 68Ga-PSMA-11 PET on patient management and outcome, including all patients referred for an increase in PSA level during the first year after its clinical introduction.
Müller J, Ferraro DA, Muehlematter UJ, Garcia Schüler HI, Kedzia S, Eberli D, Guckenberger M, Kroeze SGC, Sulser T, Schmid DM, Omlin A, Müller A, Zilli T, John H, Kranzbuehler H, Kaufmann PA, von Schulthess GK, Burger IA. Müller J, et al. Among authors: burger ia. Eur J Nucl Med Mol Imaging. 2019 Apr;46(4):889-900. doi: 10.1007/s00259-018-4203-0. Epub 2018 Nov 28. Eur J Nucl Med Mol Imaging. 2019. PMID: 30488099
68Ga-PSMA-11 PET has the potential to improve patient selection for extended pelvic lymph node dissection in intermediate to high-risk prostate cancer.
Ferraro DA, Muehlematter UJ, Garcia Schüler HI, Rupp NJ, Huellner M, Messerli M, Rüschoff JH, Ter Voert EEGW, Hermanns T, Burger IA. Ferraro DA, et al. Among authors: burger ia. Eur J Nucl Med Mol Imaging. 2020 Jan;47(1):147-159. doi: 10.1007/s00259-019-04511-4. Epub 2019 Sep 14. Eur J Nucl Med Mol Imaging. 2020. PMID: 31522272
Impact of 68Ga-PSMA-11 PET staging on clinical decision-making in patients with intermediate or high-risk prostate cancer.
Ferraro DA, Garcia Schüler HI, Muehlematter UJ, Eberli D, Müller J, Müller A, Gablinger R, Kranzbühler H, Omlin A, Kaufmann PA, Hermanns T, Burger IA. Ferraro DA, et al. Among authors: burger ia. Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):652-664. doi: 10.1007/s00259-019-04568-1. Epub 2019 Dec 4. Eur J Nucl Med Mol Imaging. 2020. PMID: 31802175
Improved oncological outcome after radical prostatectomy in patients staged with 68Ga-PSMA-11 PET: a single-center retrospective cohort comparison.
Ferraro DA, Lehner F, Becker AS, Kranzbühler B, Kudura K, Mebert I, Messerli M, Hermanns T, Eberli D, Burger IA. Ferraro DA, et al. Among authors: burger ia. Eur J Nucl Med Mol Imaging. 2021 Apr;48(4):1219-1228. doi: 10.1007/s00259-020-05058-5. Epub 2020 Oct 19. Eur J Nucl Med Mol Imaging. 2021. PMID: 33074376 Free PMC article.
Whole-body parametric [18F]-FDG PET/CT improves interpretation of a distant lesion as venous embolus in a lung cancer patient.
Messerli M, Kotasidis F, Ferraro DA, Kudura K, Treyer V, Trinckauf J, Weyermann C, Hüllner M, Kaufmann P, Burger IA. Messerli M, et al. Among authors: burger ia. Eur J Nucl Med Mol Imaging. 2021 Jun;48(6):2047-2048. doi: 10.1007/s00259-020-05176-0. Epub 2021 Jan 15. Eur J Nucl Med Mol Imaging. 2021. PMID: 33452635 Free PMC article. No abstract available.
195 results